Position in QGEN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,209,384
+$10,548 QoQ
Shares Held
56,506
+2.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#134
of 336 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $199,150,782 across 8 Diagnostics & Research names. QGEN ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
653,183 | $124,418,297 | |
| 2 | LH |
Labcorp Holdings Inc.
|
218,731 | $61,244,680 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
18,789 | $4,261,157 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
5,866 | $2,940,977 | |
| 5 | DGX |
Quest Diagnostics Inc
|
12,820 | $2,717,199 | |
| 6 | QGEN |
Qiagen N.V.
This page
|
56,506 | $2,209,384 | |
| 7 | WAT |
Waters Corp /De/
|
2,473 | $927,473 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
815 | $431,615 |
All Filings in QGEN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,209,384 | 56,506 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,198,836 | 54,916 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,579,434 | 57,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,562,800 | 57,359 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,745,139 | 57,119 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,272,490 | 56,600 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,597,880 | 58,340 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||